Amyris to Present at Four Upcoming Investor Conferences in December

EMERYVILLE, Calif., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq: AMRS), the industrial bioscience company, today announced that it plans to participate in the following upcoming investor conferences in December 2016.

Drexel Hamilton Emerging Growth ConferenceDecember 1, 2016Drexel’s offices, New York, NY

Benchmark & Company Micro Cap Discovery One-on-One ConferenceDecember 1, 2016Palmer House Hilton Hotel, Chicago, IL

LD Micro Main Event 2016 ConferenceDecember 8, 2016Luxe Sunset Boulevard Hotel, Los Angeles, CA

Roth Capital Partners 4th New Industrials Corporate Access DayDecember 13, 2016Lotte New York Palace Hotel, New York NY

Amyris will provide an update on its business during these events. Live webcasts of the presentations at Drexel Hamilton (2:00 p.m. ET) and LD Micro (10:00 a.m. PT/1:00 p.m. ET), including slides and a replay will be available on the investor relations section of the company’s website at http://investors.amyris.com. Due to the one-on-one format of the Benchmark and Roth events, no webcasts will be available.

About AmyrisAmyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, and pharmaceuticals and nutraceuticals. More information about the company is available at www.amyris.com.

Amyris and the Amyris logo are registered trademarks of Amyris, Inc.

Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
[email protected]
[email protected]

You May Also Be Interested In

• ACTS LAW Addresses Federal Correctional Institution in Dublin Controversy
• BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
• First Mid Bancshares, Inc. Announces First Quarter 2024 Results